117 related articles for article (PubMed ID: 37036040)
1. Albumin-based solution is the ideal post-thawing suspension medium for cord blood hematopoietic stem cells: A stability and proliferative evaluation.
Lachica CA; Miele MJ; Herrera SM; Elanbari M; Deola S; Saleh A; Ejaz A; Aftab S; Olagunju D; Laoun R; Cugno C
Transfusion; 2023 May; 63(5):1050-1059. PubMed ID: 37036040
[TBL] [Abstract][Full Text] [Related]
2. The influence of temperature treatment before cryopreservation on the viability and potency of cryopreserved and thawed CD34
Schwandt S; Liedtke S; Kogler G
Cytotherapy; 2017 Aug; 19(8):962-977. PubMed ID: 28645734
[TBL] [Abstract][Full Text] [Related]
3. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
4. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
[TBL] [Abstract][Full Text] [Related]
5. Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.
Duchez P; Chevaleyre J; Brunet de la Grange P; Vlaski M; Boiron JM; Wouters G; Ivanovic Z
Transfusion; 2013 Sep; 53(9):2012-9. PubMed ID: 23227804
[TBL] [Abstract][Full Text] [Related]
6. The effect of cell concentrations from different cell populations on the viability of umbilical blood stem cells.
Hauck-Dlimi B; Dlimi A; Zimmermann R; Eckstein R; Zingsem J
Clin Lab; 2014; 60(10):1635-40. PubMed ID: 25651708
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation.
Kurtz J; Seetharaman S; Greco N; Moroff G
Transfusion; 2007 Sep; 47(9):1578-87. PubMed ID: 17725720
[TBL] [Abstract][Full Text] [Related]
8. Quality comparison of umbilical cord blood cryopreserved with conventional versus automated systems.
Kim KM; Huh JY; Kim JJ; Kang MS
Cryobiology; 2017 Oct; 78():65-69. PubMed ID: 28716596
[TBL] [Abstract][Full Text] [Related]
9. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs.
Bueno C; Montes R; Menendez P
Stem Cell Rev Rep; 2010 Jun; 6(2):215-23. PubMed ID: 20180051
[TBL] [Abstract][Full Text] [Related]
10. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB.
Stylianou J; Vowels M; Hadfield K
Cytotherapy; 2006; 8(1):57-61. PubMed ID: 16627345
[TBL] [Abstract][Full Text] [Related]
11. Study of a new device for washing and concentrating cryopreserved hematopoietic stem cells and mononuclear cells: a single center experience.
Santurette CC; Charron M; Bouyer S; Houzé P; Binninger S; Lavergne A; Mercier M; Giraud C
Cytotherapy; 2022 Jan; 24(1):86-92. PubMed ID: 34690062
[TBL] [Abstract][Full Text] [Related]
12. Thawing methods do not affect cell viability of CD45+ and CD34+ cells, but long-term cryopreservation of umbilical cord blood units generally decreases cell viability.
Dimas-González J; Nieto-Linares A; Millán-Rocha M; Salazar-Bailón JL; Lorenzo-Moreno BA; Rojo-Medina J
Transfus Apher Sci; 2019 Apr; 58(2):196-200. PubMed ID: 30902449
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DMSO dextrose as a suitable alternative for DMSO dextran in cord blood cryopreservation.
Raffo D; Perez Tito L; Pes ME; Fernandez Sasso D
Vox Sang; 2019 Apr; 114(3):283-289. PubMed ID: 30734294
[TBL] [Abstract][Full Text] [Related]
14. Recovery of cord blood hematopoietic progenitors after successive freezing and thawing procedures.
Timeus F; Crescenzio N; Saracco P; Doria A; Fazio L; Albiani R; Cordero Di Montezemolo L; Perugini L; Incarbone E
Haematologica; 2003 Jan; 88(1):74-9. PubMed ID: 12551830
[TBL] [Abstract][Full Text] [Related]
15. Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
Mfarrej B; Vicari O; Ouffai S; Malenfant C; Granata A; Thevenet S; Chabannon C; Lemarié C; Calmels B
J Transl Med; 2022 Nov; 20(1):503. PubMed ID: 36329460
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch is an alternative washing solution for peripheral bloodstem cells products.
Larrea L; Castro E; Vera B; Vayá MJ; Yagüe N; Mirabet V; Arbona C
Transfus Apher Sci; 2021 Feb; 60(1):102915. PubMed ID: 32919883
[TBL] [Abstract][Full Text] [Related]
17. Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols.
Querol S; Capmany G; Azqueta C; Gabarró M; Fornas O; Martín-Henao GA; García J
Transfusion; 2000 Jun; 40(6):625-31. PubMed ID: 10864979
[TBL] [Abstract][Full Text] [Related]
18. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
[TBL] [Abstract][Full Text] [Related]
19. Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation.
Yang H; Acker JP; Cabuhat M; McGann LE
Bone Marrow Transplant; 2003 Nov; 32(10):1021-6. PubMed ID: 14595390
[TBL] [Abstract][Full Text] [Related]
20. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.
Minegishi M; Itoh T; Fukawa N; Kitaura T; Miura J; Takahashi H; Suzuki A; Kudo Y; Narita A; Sato Y; Suzuki M; Watanabe T; Wada Y; Takeyama Y; Tsuchiya S
Int J Hematol; 2007 Jan; 85(1):78-84. PubMed ID: 17261506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
